Boston IVF Joins Rebranded Everleap Fertility as Survey Is Released
The survey of 24,074 women in nine countries found 21% of U.S. women have experienced infertility, but only 17% of those who saw a doctor pursued IVF.
· 1 min read
Boston IVF is now part of Everleap Fertility, the new brand name for IVI RMA North America, the company said on October 13 in announcing the first results of a nine-country fertility survey.
The rebrand combines Boston IVF with RMA, Conceptions and six other U.S. fertility practices under a single name, spanning more than 65 locations and 25 IVF laboratories, according to the announcement distributed by PR Newswire. Everleap Fertility is part of IVI Institute, formerly IVI RMA Global, which operates more than 200 clinics in 15 countries.
The accompanying IVI Institute Fertility Barometer surveyed 24,074 women aged 19 to 49 in Canada, France, Italy, Spain, Sweden, Portugal, the United Arab Emirates, the United Kingdom and the United States between May 16 and July 3, 2026, in partnership with GfK, a NielsenIQ company. The margin of error was ±0.63 percentage points.
Among U.S. findings, 83% of women surveyed are mothers or want children and 75% called motherhood a priority, while 34% of those with a target age had their first child later than they wanted. About 21% have experienced infertility, and more than 72% of them consulted a doctor, but only 17% went through IVF, with cited deterrents including doubts about success, emotional stress and cost.
Lynn Mason, chief executive of Everleap Fertility, said many women lack "the information, guidance, or support" to understand their options.
This story was first reported by PR Newswire.
Comments